Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Heat Effect
Interventions: Lidocaine patch; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 45 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson's Disease
Interventions: nicotine transdermal patch; Drug
Lead sponsor: James BOYD MD; Other
Eligibility: 30 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 9
States / cities: Los Angeles, California • Sunnyvale, California • Honolulu, Hawaii + 6 more

Conditions: Osteosarcoma
Interventions: standard of care biopsy; Other
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Feasibility Study, Medical Device
Interventions: sphygmomanometer, Arterial Line; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 90 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Knee Injuries, Cartilage Injury, Cartilage Disease, Knee Discomfort
Interventions: Microfracture, Microfracture plus placement of Chondro-Gide® ACC; Procedure · Device
Lead sponsor: Geistlich Pharma AG; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Phoenix, Arizona • Stamford, Connecticut • Johns Creek, Georgia

Conditions: Opioid Use
Interventions: Information Sheet, Deterra Drug Deactivation System; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 391 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Drug Addiction, Smoking Cessation
Interventions: Nicotine transdermal system, Nicotine containing cigarette, Placebo cigarette; Drug · Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Arteriovenous Fistula
Interventions: Covera Vascular Covered Stent; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • New Haven, Connecticut • Westmont, Illinois + 8 more

Conditions: Colorectal Neoplasm, Hepatic Neoplasm
Interventions: DCE-MRI; Other
Lead sponsor: American College of Radiology; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 5
States / cities: Hershey, Pennsylvania • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Smoking Cessation, Alcohol Drinking
Interventions: Chantix, Behavioral Counseling Sessions, NicodermCQ, Placebo; Drug · Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 85 Years
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Metastatic Prostate Cancer, Cancer of the Prostate, Prostate Cancer
Interventions: Anti-OX40, Radiation, Cyclophosphamide; Drug · Radiation
Lead sponsor: Providence Health & Services; Other
Eligibility: 18 Years and older · Male only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Protruded Disk
Interventions: CLARIX™100, CLARIX CORD 1K; Other
Lead sponsor: Amniox Medical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: Bensalem, Pennsylvania

Conditions: Lung Cancer
Interventions: Smoking cessation intervention, Counseling intervention, Nicotine patch; Behavioral · Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years to 65 Years
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cardiovascular Risk Reduction
Interventions: Estradiol 100 Micrograms Patch, Estradiol Patch; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prurigo Nodularis
Interventions: Ruxolitinib Cream 1.5%; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 20
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Fountain Valley, California + 17 more

Conditions: Tennis Elbow, Lateral Epicondylitis
Interventions: Smith & Nephew Bioinductive Implant, Lateral Epicondylectomy, Ultrasound Imaging; Biological · Procedure · Radiation
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Tobacco Use Cessation, Tobacco Cessation, Tobacco Use Disorder, Tobacco Dependence, Tobacco-Use Disorder, Virus, Human Immunodeficiency
Interventions: Web-Based Tailored Smoking Cessation Intervention, Standard of Care; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years and older
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Cystic Fibrosis
Interventions: Pilocarpine microneedle patch, Pilocarpine Iontophoresis; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, Histiocytic Disorders
Interventions: F-choline PET Scan, FDG-PET, biopsy; Radiation · Device · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteo Arthritis Knee, Arthritis
Interventions: Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, 2.5% Diclofenac Patches, SAM Patch; Device · Drug · Other
Lead sponsor: ZetrOZ, Inc.; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 307 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: Stamford, Connecticut • Trumbull, Connecticut • Dryden, New York

Conditions: Arteriovenous Fistula, Arteriovenous Fistula Stenosis, Arteriovenous Fistula Occlusion, Fistula
Interventions: IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort, IN.PACT™ AV Drug Coated Balloon (DCB) - Extended Cohort; Combination Product
Lead sponsor: Medtronic; Industry
Eligibility: 21 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 20
States / cities: Los Angeles, California • Stanford, California • New Haven, Connecticut + 17 more

Conditions: Prostate Cancer, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Localized Prostate Carcinoma
Interventions: Focal laser ablation of the prostate; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years and older · Male only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract
Interventions: Not listed
Lead sponsor: California Pacific Medical Center Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 8,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Anal Cancer, Precancerous Condition
Interventions: infrared photocoagulation therapy, Infrared Coagulator; Procedure · Device
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 2
States / cities: San Francisco, California • New York, New York

Search by objective public record fields.

PK and DPK of Lidocaine Dermal Products

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma

Clinical Feasibility of a Conformal Ultrasound Blood Pressure Sensor

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Pain and Medication Use Following Surgery

Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3

Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft

Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI

Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

CLARIX™ 100 & CLARIX CORD 1K for Discectomy Patients

Computer-Assisted Counseling in Helping African American Smokers Stop Smoking

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Efficacy Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)

Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV

Pilocarpine Microneedles for Sweat Induction (PMN-SI)

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

IN.PACT™ AV Access Post-Approval Study (PAS002)

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia